VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Core Viewpoint - Investors in Vistagen Therapeutics, Inc. have the opportunity to lead a securities fraud lawsuit against the company with the Schall Law Firm [1] Group 1 - The lawsuit is centered around allegations of securities fraud involving Vistagen Therapeutics, Inc. [1] - The Schall Law Firm is actively seeking investors who wish to participate in the lawsuit [1] - This legal action presents a potential avenue for investors to address grievances related to the company's practices [1]